NEW YORK, Nov. 8 – Lion Bioscience said Thursday its fiscal second quarter revenues more than doubled to 10.2 million euros ($9.1 million), compared with 4.5 million euros in the year ago period, as revenues from research and development fees tripled.

Such fees accounted for 6.0 million of Lion’s second-quarter revenues, compared with 1.4 million euros a year ago. Revenues from software licenses jumped 38 percent to 4.3 million euros, compared with 3.1 million a year ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.